Cargando…
Repetitive administration of cultured human CD34+ cells improve adenine-induced kidney injury in mice
BACKGROUND: There is no established treatment to impede the progression or restore kidney function in human chronic kidney disease (CKD). AIM: To examine the efficacy of cultured human CD34+ cells with enhanced proliferating potential in kidney injury in mice. METHODS: Human umbilical cord blood (UC...
Autores principales: | Ohtake, Takayasu, Itaba, Shoichi, Salybekov, Amankeldi A, Sheng, Yin, Sato, Tsutomu, Yanai, Mitsuru, Imagawa, Makoto, Fujii, Shigeo, Kumagai, Hiroki, Harata, Masamitsu, Asahara, Takayuki, Kobayashi, Shuzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173816/ https://www.ncbi.nlm.nih.gov/pubmed/37181001 http://dx.doi.org/10.4252/wjsc.v15.i4.268 |
Ejemplares similares
-
CD34 positive cells as endothelial progenitor cells in biology and medicine
por: Hassanpour, Mehdi, et al.
Publicado: (2023) -
Characterization of Endothelial Progenitor Cell: Past, Present, and Future
por: Salybekov, Amankeldi A., et al.
Publicado: (2022) -
Therapeutic application of regeneration-associated cells: a novel source of regenerative medicine
por: Salybekov, Amankeldi A., et al.
Publicado: (2023) -
Latest Advances in Endothelial Progenitor Cell-Derived Extracellular Vesicles Translation to the Clinic
por: Salybekov, Amankeldi A., et al.
Publicado: (2021) -
Personalized Cell Therapy for Patients with Peripheral Arterial Diseases in the Context of Genetic Alterations: Artificial Intelligence-Based Responder and Non-Responder Prediction
por: Salybekov, Amankeldi A., et al.
Publicado: (2021)